EPISODE · Sep 29, 2016 · 43 MIN
Companies & Markets Show 30 September 2016
from Investors' Chronicle
Good drugs and bad banks: In our 100th episode, editor John Hughman and the companies team talk about the bubbling drug discovery pipeline and the ongoing troubles of Europe's banking industryInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
NOW PLAYING
Companies & Markets Show 30 September 2016
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.